Nov 15, 2024, 17:45
Osteopontin as a therapeutic target in Breast Cancer recurrence
A recent paper by Yu Gu, PhD Candidate at McGill University, was mentioned by Dana-Farber’s Breast Oncology Center on X:
“New now out in Nature Communications.”
“Osteopontin is a therapeutic target that drives breast cancer recurrence”
Authors:
More posts featuring Dana-Farber’s Breast Oncology Center.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12